ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

5 Revealing Analyst Questions From Hillenbrand’s Q2 Earnings Call

HI Cover Image

Hillenbrand’s second quarter saw revenue ahead of Wall Street’s expectations, despite a substantial year-over-year decline. Management attributed the quarter’s results to continued cautious order behavior amid macroeconomic uncertainty and recent tariff announcements, especially in its Advanced Process Solutions segment. CEO Kimberly K. Ryan explained, “We continued to experience cautious order behavior from customers amid continued global macroeconomic uncertainty and tariff announcements,” emphasizing that project delays rather than cancellations were the primary issue. The company also completed portfolio simplification steps, including divesting its Milacron Injection Molding & Extrusion business and a minority stake in TerraSource, using proceeds to reduce debt.

Is now the time to buy HI? Find out in our full research report (it’s free).

Hillenbrand (HI) Q2 CY2025 Highlights:

  • Revenue: $598.9 million vs analyst estimates of $572.5 million (23.9% year-on-year decline, 4.6% beat)
  • Adjusted EPS: $0.51 vs analyst estimates of $0.50 (3% beat)
  • Adjusted EBITDA: $84.3 million vs analyst estimates of $85.44 million (14.1% margin, 1.3% miss)
  • The company slightly lifted its revenue guidance for the full year to $2.61 billion at the midpoint from $2.59 billion
  • Management reiterated its full-year Adjusted EPS guidance of $2.28 at the midpoint
  • EBITDA guidance for the full year is $377.5 million at the midpoint, above analyst estimates of $373.1 million
  • Operating Margin: 8.4%, down from 11.8% in the same quarter last year
  • Backlog: $1.62 billion at quarter end
  • Market Capitalization: $1.77 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Hillenbrand’s Q2 Earnings Call

  • Daniel Joseph Moore (CJS Securities) asked about the drivers of recent order upticks in Advanced Process Solutions. CEO Kimberly K. Ryan indicated strength in plastics—both polyolefin and engineering plastics—and highlighted the impact of close customer relationships in securing these orders.
  • Moore (CJS Securities) also questioned improved demand and quoting activity in the MTS segment. Ryan noted increased quoting and orders in India and stability in China, emphasizing new product launches for local markets.
  • Moore (CJS Securities) probed cash flow normalization and leverage. Interim CFO Megan Walke stated that leverage will remain stable in the near term but should improve as order momentum accelerates and cash advances are collected.
  • Matt J. Summerville (D.A. Davidson) inquired about order activity in Food, Health and Nutrition. Ryan described order stability and outlined opportunities for growth through expanded cross-selling and leveraging existing Coperion infrastructure.
  • Mitchell Brian Moore (KeyBanc Capital Markets) asked about the impact of tariffs and whether recent improvements in order activity could drive backlog growth by year-end. Ryan responded that while a clear trend has not yet emerged, ongoing customer engagement and full test labs are encouraging signs.

Catalysts in Upcoming Quarters

Looking ahead, our analysts are watching (1) the pace and consistency of order recovery in Advanced Process Solutions as customers adapt to new tariff realities, (2) measurable progress in commercial integration and cross-selling within Food, Health and Nutrition, and (3) whether recent cost synergies and portfolio moves continue to support margin stability. The timing and magnitude of backlog growth will be a key marker for sustained recovery.

Hillenbrand currently trades at $24.28, up from $19.80 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.